Magnified view of fiber optic threads

Pioneer the Possible

Nasdaq Biotech Index

Learn More Ways to Invest
With disruption in our DNA, we are home to today’s top and emerging biotech companies, helping them pioneer a better tomorrow.

The Benchmark for Technology-Driven Healthcare Innovation

BioTechnology Index

With its rules-based, transparent index methodology utilizing modified market cap-weighting, the Nasdaq Biotechnology Index (NBI) reflects the dynamic, innovation-driven world of Nasdaq-listed biotech companies. NBI captures hundreds of constituents of various sizes, while ensuring that the largest, most important players in the space are weighted appropriately.

Year in Review Read the Report

Index Charts & Data

Top 10 Index Weights as of December 31, 2021 (%)

Top 10 Index Weights: FY'21 vs. FY'20 Returns (%)

Investing in Biotech with Nasdaq Index

Invesco Nasdaq Biotechnology ETF

Biotech is paving the way for a post-pandemic world. Through the Invesco Nasdaq Biotechnology ETF, access a high concentration of companies critical to COVID-19 vaccines and treatments, as well as the continued growth of genomics, wellness and advanced medical therapeutics.

Learn More

ETPs Tracking NBI

Given the strength of the Nasdaq Biotech Index, numerous exchange-traded products are tracking the index. From Asia to North America and Europe to the Middle East, discover the global reach of NBI.

Learn More

'We are excited to expand our relationship with Nasdaq in order to offer investors another way to access innovative companies currently shaping the way we live and work.'

- Anna Paglia, Global Head of ETFs and Indexed Strategies, Invesco

Learn More

Nasdaq Biotech Index on TradeTalks

Trends In Biotech Listings And IPO Pipeline
Nasdaq Head of Healthcare Listings, & Capital Markets Jordan Saxe joins Jill Malandrino on TradeTalks to discuss trends in biotech listings and IPO pipeline. #NationalBiotechnologyMonth
Jan 31, 2022
1 / 7
Pillars of Possibilities

Home to 600+ Biotech Companies

Backing BioTech Since the Beginning

We've backed biotech for 50 years and counting, providing the disruptors and innovators with a place to call home and access to the capital they need to propel their businesses forward. 98% of U.S. Listed Biotech Companies are listed on Nasdaq.

Learn More
Accelerate Innovation

Unlocking Opportunity

We connect today's biotech trailblazers and titans with the capital they need to unlock opportunity and accelerate innovation that transforms lives.

Quarter of a Century

Benchmarking Innovation

The Nasdaq Biotech Index has provided a benchmark for biotech innovation for more than 25 years.

Global Impact

Investing in Tomorrow

Learn how to invest in the Nasdaq Biotech Index and help accelerate the global impact of the companies who are changing the world.

We are the home to Biotech because we committed to the industry from the very beginning. Our gateway to the capital markets allows researchers, scientists and business leaders to pioneer the possible every day—and we are proud to be with them at every step of that journey.
Jordan Saxe, Head of Healthcare Listings, Nasdaq

NBI in the News

Nasdaq: MRNA

Moderna Announces FDA Authorization of Its COVID-19 Vaccine in U.S.

In December 2020, Moderna COVID-19 Vaccine was authorized for distribution and use under an Emergency Use Authorization (EUA). Delivery to the U.S. Government began immediately.

Read the Article
Nasdaq: AMGN

Amgen Wins Approval for Pathbreaking Lung Cancer Drugs

A potential blockbuster, this new drug is first to treat common cancer mutation called KRAS that researchers struggled for years to target.

Read the Article
Nasdaq: BNTX

BioNTech to roll out mRNA Production in Africa

Pharmaceutical company BioNTech has announced plans to establish mRNA vaccine production facilities in Africa — part of a larger plan to combat diseases on the continent.

Read the Article
Live Index Performance View real-time performance data and historical index trends on the Global Index Watch (GIW) website. View Live Data

Global Index Resources

Research & Insights

Explore In-Depth Market Research

Index Education Hub

Access Foundational Learning
What's Next For the Innovators of the Nasdaq Biotechnology Index?

Biotech's Post-Covid Future

Learn what drove biotech performance in the pivotal year of 2021, and why having the proper benchmark for this unique industry is more important than ever. Along with a special guest from Nasdaq-listed BioMarin Pharmaceutical, take a deep dive into some of the cutting-edge innovation happening within the space, especially as it relates to gene therapy for the treatment of rare diseases.

Register Now

We are actively working to enhance your experience by translating more content. However, please be aware that the page you are about to visit has not yet been translated.


We appreciate your understanding and patience as we continue to improve our services.

Continue

AI Translation

Our translation tool strives for accuracy, yet no machine translation is flawless or a substitute for human translators. Translations are offered as a convenience, "as is." We do not guarantee the accuracy, reliability, or correctness of translations from English to other languages. Certain content may not translate accurately due to software limitations.The original English text prevails on the website. Variances in translation are non-binding and hold no legal weight for compliance or enforcement. For queries about translated content accuracy, consult the official English version of our site.

Accuracy
Fluency
Clarity
Cultural Relevance
Terminology
Additional Comments (optional)

Submit